UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 25, 2025 4:15 P.M.
Form:
S-4
CIK:
0001798749
Company Name:
Aerovate Therapeutics, Inc.
File Number:
333-283562